Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease
- PMID: 24953895
- PMCID: PMC4253902
- DOI: 10.1016/j.jvs.2014.05.040
Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease
Abstract
Objective: Despite available medical therapies, patients with peripheral arterial disease (PAD) remain at high risk for cardiovascular events. The n-3 polyunsaturated fatty acids (PUFA), derived from marine sources, have been shown to improve cardiovascular mortality. The Omega-3 Index (O3I), a proportion of the n-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the red blood cell membrane, correlates with cardiovascular risk. Previous investigations have found that n-3 PUFA supplementation, fish consumption, older age, and smoking history affect the O3I in different patient populations, although similar correlations have never been explored in PAD. We hypothesized that in our PAD cohort, blood content of omega-3 fatty acids would directly and positively correlate with a history of fish oil supplementation and older age and inversely correlate with a smoking history and obesity.
Methods: This cross-sectional study included 111 patients who had an ankle-brachial index of <0.9 associated with claudication symptoms. We used linear regression to determine the association between clinical factors and the O3I.
Results: The mean age of the cohort was 69 ± 8 years; 37% had diabetes mellitus (hemoglobin A1c, 7% ± 1%), and 94% reported current smoking or a history of smoking. The mean O3I was 5% ± 2%. In multivariate linear regression analysis, the O3I was associated with older age, increasing body mass index, and a history of smoking and fish oil intake.
Conclusions: This is the first report of the relation between blood content of omega-3 fatty acids and clinical factors in a PAD population. In patients with PAD, older age, elevated body mass index, and prior fish oil supplementation predicted a higher O3I. A history of smoking correlated with a lower O3I. These results demonstrate that the O3I is a reliable measure of dietary n-3 PUFA intake and that clinical factors related to the O3I in PAD are similar to those observed in other populations.
Published by Elsevier Inc.
Conflict of interest statement
WSH is the President of OmegaQuant Analytics, LLC and a Senior Research Scientist and Health Diagnostic Library, Inc., both of which offer the blood omega-3 testing. The remaining authors do not have anything to disclose.
Similar articles
-
Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.J Surg Res. 2017 Apr;210:124-131. doi: 10.1016/j.jss.2016.11.011. Epub 2016 Nov 11. J Surg Res. 2017. PMID: 28457318 Free PMC article. Clinical Trial.
-
Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.Nutr Res. 2019 Nov;71:43-55. doi: 10.1016/j.nutres.2019.09.001. Epub 2019 Sep 11. Nutr Res. 2019. PMID: 31757628
-
Association of reported fish intake and supplementation status with the omega-3 index.Prostaglandins Leukot Essent Fatty Acids. 2019 Mar;142:4-10. doi: 10.1016/j.plefa.2019.01.002. Epub 2019 Jan 11. Prostaglandins Leukot Essent Fatty Acids. 2019. PMID: 30773210
-
The influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: A scoping review.Front Nutr. 2023 Jan 19;10:1072653. doi: 10.3389/fnut.2023.1072653. eCollection 2023. Front Nutr. 2023. PMID: 36742439 Free PMC article.
-
The effect of n-3 polyunsaturated fatty acid supplementation on cognitive function outcomes in the elderly depends on the baseline omega-3 index.Food Funct. 2023 Oct 30;14(21):9506-9517. doi: 10.1039/d3fo02959j. Food Funct. 2023. PMID: 37840364 Review.
Cited by
-
Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.J Surg Res. 2017 Apr;210:124-131. doi: 10.1016/j.jss.2016.11.011. Epub 2016 Nov 11. J Surg Res. 2017. PMID: 28457318 Free PMC article. Clinical Trial.
-
Smoking and red blood cell phospholipid membrane fatty acids.Prostaglandins Leukot Essent Fatty Acids. 2016 Sep;112:24-31. doi: 10.1016/j.plefa.2016.08.004. Epub 2016 Aug 16. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 27637337 Free PMC article.
-
Maximal exercise and erythrocyte fatty-acid status: a lipidomics study.Physiol Rep. 2019 Apr;7(8):e14040. doi: 10.14814/phy2.14040. Physiol Rep. 2019. PMID: 31016868 Free PMC article. Clinical Trial.
-
Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.FASEB J. 2015 Jun;29(6):2504-13. doi: 10.1096/fj.14-265363. Epub 2015 Mar 16. FASEB J. 2015. PMID: 25777995 Free PMC article.
-
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers.Trials. 2021 Dec 14;22(1):922. doi: 10.1186/s13063-021-05865-7. Trials. 2021. PMID: 34906201 Free PMC article.
References
-
- Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA : the journal of the American Medical Association. 2001 Sep 19;286(11):1317–1324. - PubMed
-
- Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006 Aug 15;114(7):688–699. - PubMed
-
- Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S. Nutrition impacts the prevalence of peripheral arterial disease in the United States. Journal of vascular surgery. 2008 Oct;48(4):897–904. - PubMed
-
- Norman PE, Powell JT. Vitamin d and cardiovascular disease. Circulation research. 2014 Jan 17;114(2):379–393. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical